Contravisory Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-536
Closed -$49K 310
2019
Q1
$49K Buy
536
+56
+12% +$5.01K 0.02% 224
2018
Q4
$44K Buy
480
+330
+220% +$30.8K 0.02% 214
2018
Q3
$15K Buy
+150
New +$13.9K 0.01% 227
2018
Q1
Sell
-21
Closed -$2K 405
2017
Q4
$2K Hold
21
﹤0.01% 332
2017
Q3
$2K Buy
+21
New +$1.74K ﹤0.01% 361
2017
Q1
Sell
-593
Closed -$42K 325
2016
Q4
$42K Hold
593
0.01% 132
2016
Q3
$51K Sell
593
-6
-1% -$523 0.02% 99
2016
Q2
$52K Sell
599
-2,214
-79% -$179K 0.02% 92
2016
Q1
$211K Sell
2,813
-579
-17% -$43.6K 0.06% 57
2015
Q4
$261K Sell
3,392
-8
-0.2% -$602 0.07% 56
2015
Q3
$228K Sell
3,400
-385
-10% -$28.4K 0.05% 58
2015
Q2
$280K Hold
3,785
0.06% 52
2015
Q1
$295K Sell
3,785
-530
-12% -$40.2K 0.06% 49
2014
Q4
$312K Sell
4,315
-1,250
-22% -$86.8K 0.06% 46
2014
Q3
$345K Hold
5,565
0.07% 46
2014
Q2
$355K Sell
5,565
-250
-4% -$15.2K 0.07% 52
2014
Q1
$358K Buy
+5,815
New +$339K 0.07% 56

Other funds holding MDT

Contravisory Investment Management's MDT Position: Q2 2019 in Review

Contravisory Investment Management sold out of Medtronic (MDT) in Q2 2019, closing a stake of 536 shares — an estimated $49K sold.

Contravisory Investment Management first reported a position in MDT in Q1 2014 and held it in 17 quarters. The position peaked at $358K in Q1 2014. 1,619 funds tracked by Wall St. Rank hold MDT as of Q2 2019.

  • Contravisory Investment Management reported no remaining Medtronic position as of Q2 2019 after selling out during the quarter.
  • Contravisory Investment Management sold 536 Medtronic shares in Q2 2019, an estimated $49K.
  • Contravisory Investment Management first reported a position in Medtronic in Q1 2014 and held it in 17 quarters.
  • Contravisory Investment Management's Medtronic position peaked at $358K in Q1 2014.
  • 1,619 funds tracked by Wall St. Rank held Medtronic as of Q2 2019.

Based on Contravisory Investment Management's 13F filing for Q2 2019, filed 9 Jul 2019.